(GLP-1 = Glucagon-like peptide-1 receptor agonists, e.g., semaglutide, liraglutide, dulaglutide, tirzepatide) GLP-1 agonists may offer multi-targeted benefits in Long COVID by reducing inflammation, repairing endothelial...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Related Posts